Development of a peptide ELISA to discriminate vaccine-induced immunity from natural infection of hepatitis A virus in a phase IV study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2017-06-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10096-017-3040-6PMID 28631170
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serological Evaluation of Immunity to the Varicella-Zoster Virus Based on a Novel Competitive Enzyme-Linked Immunosorbent Assay

  2016cited by this paper
• Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.

  2016cited by this paper
• Hepatitis A virus: host interactions, molecular epidemiology and evolution.

  2014cited by this paper
• Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®

  2012cited by this paper
• An outbreak of hepatitis A in recently vaccinated students from ice snacks made from contaminated well water

  2008cited by this paper
• Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community.

  2008cited by this paper
• Diagnosis of Hepatitis A Virus Infection: a Molecular Approach

  2006cited by this paper
• What Is a Pneumococcus

  2004cited by this paper
• Intrinsic Signals for the Assembly of Hepatitis A Virus Particles

  1999cited by this paper
• Antigenic epitopes of the hepatitis A virus polyprotein.

  1999cited by this paper
• [Hepatitis A virus].

  1995cited by this paper
• Antibody response to nonstructural proteins of hepatitis A virus following infection

  1993cited by this paper
• Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.

  1992cited by this paper
• Expression of the aphthovirus RNA polymerase gene in Escherichia coli and its use together with other bioengineered nonstructural antigens in detection of late persistent infections.

  1991cited by this paper
• Primary study of attenuated live hepatitis A vaccine (H2 strain) in humans.

  1989cited by this paper
• Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses

  1987cited by this paper
• Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase.

  1983cited by this paper
• Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay

  1977cited by this paper
• A third antigenic component associated with foot-and-mouth disease infection.

  1966cited by this paper

• Mapping disparities in viral infection rates using highly multiplexed serology

  2024cites this paper
• Hepatitis A seroprevalence, vaccination status and demographic determinants in children and adolescents in Germany, 2014–2017, a population-based study

  2023cites this paper
• Humoral and cellular immune memory response 12 years following single dose vaccination against hepatitis A in Argentinian children.

  2021cites this paper
• Hepatitis A vaccination and its immunological and epidemiological long-term effects – a review of the evidence

  2020cites this paper
• Hepatitis A virus infections, immunisations and demographic determinants in children and adolescents, Germany

  2018cites this paper
• Response to comment on: Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology.

  2018cites this paper
• Serologic differential diagnosis of hepatitis A virus (HAV) infected and vaccinated individuals: How long persist antibodies to non-structural HAV proteins?

  2018cites this paper
• Development of a Bead-Based Multiplex Assay for the Analysis of the Serological Response against the Six Pathogens HAV, HBV, HCV, CMV, T. gondii, and H. pylori

  2017cites this paper